Constantine Chinoporos's most recent trade in Geron Corp. was a trade of 270,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Geron Corp | Constantine Chinoporos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2026 | 270,000 | 270,000 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Constantine Chinoporos | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 1,000,000 | 57,111 (0%) | 5% | - | Common Stock | |
| Applied Therapeutics Inc | Constantine Chinoporos | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 437,500 | 1,057,111 (5%) | 2% | 0 | Common Stock | |
| Applied Therapeutics Inc | Constantine Chinoporos | See Remarks | 19 Dec 2025 | 57,111 | 0 (0%) | 0% | - | Common Stock | ||
| Applied Therapeutics Inc | Constantine Chinoporos | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 350,000 | 621,436 (3%) | 1% | 0 | Common Stock | |
| Applied Therapeutics Inc | Constantine Chinoporos | See Remarks | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 04 Mar 2025 | 447 | 271,436 (1%) | 0% | 0.4 | 197 | Common Stock |
| Applied Therapeutics Inc | Constantine Chinoporos | See Remarks | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 06 Feb 2025 | 28,117 | 271,883 (1%) | 0% | 0.6 | 17,151 | Common Stock |
| Applied Therapeutics Inc | Constantine Chinoporos | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 300,000 | 300,000 (1%) | 1% | 0 | Common Stock |